1437-C PREDICTIVE VALUE OF HEPATITIS B CORE-RELATED ANTIGEN FOR CLINICAL CURE AND RELAPSE FOLLOWING PEGYLATED INTERFERON-LPHA THERAPY IN PATIENTS WITH CHRONIC HEPATITIS B AND LOW HBsAg LEVELS Ming Liu, Zhongwei Liu, Yan Guo, Hongmei Gong and Qing Mao, Department of Infectious Diseases, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China Background: Pegylated interferon- (Peg-IFN-) therapy is currently considered a promising treatment option for achieving clinical cure of chronic hepatitis B (CHB) patients
To view a copy of this licence, visit About this article Cite this article Wei, Q., Zhao, J
He wondered if the change in his skin colour would be an illusion capable of helping him cope with his memory of a disturbing and tragic past
RP Peptides supplies items strictly for laboratory and scientific research purposes only
10.1111/j.1600-0404.2010.01483.x 77 OkauchiM.HuaY.KeepR